Artimplant and Molnlycke Health Care team to develop wound care products.(Brief Article)

M2 EUROPHARMA-(C)1999-2002 M2 COMMUNICATIONS LTD

Artimplant AB and Molnlycke Health Care AB, both based in Sweden, have signed a collaboration and licensing agreement in the area of wound care.

The agreement concerns the joint development of new, highly-advanced products for the treatment of chronic wounds and burns based on Artimplant's patented technology of biodegradable polymer materials.

The two companies have for the past three years been working on a joint research project evaluating the …